key: cord-0745062-rwj0fkd6
authors: Stefano, Mancin; Andrea, Bertone; Daniela, Cattani; Emanuela, Morenghi; Lorena, Passadori; Daniela, Donizetti; Sökeland, Fanny; Azzolini, Elena; Beatrice, Mazzoleni
title: Malnutrition risk as a negative prognostic factor in COVID-19 patients
date: 2021-08-02
journal: Clin Nutr ESPEN
DOI: 10.1016/j.clnesp.2021.07.016
sha: e528fdefe1c77287770eb59b718d2b8890a721a7
doc_id: 745062
cord_uid: rwj0fkd6

Background/Objective SARS CoV-2 infection is a disease, whose prevalence has drastically risen in the past year. The aim of this study is to examine a possible association between the risk of malnutrition, clinical outcomes following hospitalisation and morbidity at discharge. Methods This study has analysed the medical records of 652 patients hospitalised at Humanitas Research Hospital (Milan, Italy) between 01/03 and 30/04/2020. The risk of malnutrition was identified with the Malnutrition Universal Screening Tool (MUST). Results The cohort was composed of 515 patients. The MUST scale is significantly associated to malnutrition evaluating the morbidity at discharge (discharged 0.27±0.68, discharged with problems 0.40±0.93, deceased 0.64±0.93, p<0.001), and the clinical outcome following hospitalisation (HR 1.25, 95% CI 1.04-1.51, p=0.019) is maintained even after correction for age, treated hypertension, admission to an intensive care unit and oxygen therapy). A subgroup analysis addressing patients with a BMI ≥ 30 shows a significant association between comorbidities such as: arterial hypertension (HR 4.95, 95% CI 1.10-22.22, p=0.037), diabetes (HR 3.37, 95% CI 1.04-10.89, p=0.043) and renal failure (HR 3.94, 95% CI 1.36-11.36, p=0.011). Conclusions The results of this study suggest that the risk of malnutrition is a noteworthy indicator that impacts both the clinical outcomes and morbidity at discharge.

Conclusions: The results of this study suggest that the risk of malnutrition is a noteworthy indicator 28 that impacts both the clinical outcomes and morbidity at discharge. 29 30 keywords: Malnutrition -SARS-CoV-2 -infection -immune system -obesity -ACE2. 31 32

Infection from SARS-CoV-2 has shown to lead to a condition of extreme clinical severity. Since its 34

first appearance until present no definitive cure has been found, even with ongoing massive 35 research efforts. Many studies have identified risk factors for unfavourable outcome, preventive 36 measures and treatments, to improve the prognostic factors of the disease. Malnutrition has been 37 recognized as one of these factors 1 . 38 Malnutrition is defined as a condition of functional, organic and developmental alteration resulting 39 from an imbalance between required nutrients, actual intake and metabolization leading to an 40 increase in mortality and morbidity affecting life quality. Such a clinical condition can result from 41 reduced intake of macro-and micronutrients, excessive intake or from an altered nutrient 42 metabolism 2 . 43

Prevalence rates of malnutrition in hospitalised patients in Europe vary according to the criteria 44 used for identification. On average 35% of newly admitted patients (range 10-80%) presents 45 malnutrition, which is generally aggravated during hospitalisation 3 . 46

Malnutrition is the main cause of immunodeficiency in the world, affecting both the innate and the 47 acquired immune response 4 , exposing individuals to an elevated risk of infection 5 and a lower 48 capacity to inhibit viral proliferation. 49

The immune system can further be altered by malnutrition due to excess food intake. Obesity  1  induces a systemic inflammatory state with consequential alteration TCD4 cell response brought  2  about by leptin, increasing autoimmunity 6 along with T-cell exhaustion characterised by reduced  3 effective, proliferative and cytotoxic function. 4

Micronutrient deficiencies are a growing problem in individuals with malnutrition, as vitamins and 5 micronutrients play an important role in allowing correct functioning of the innate and acquired 6 immune response. A state of malnutrition associated with a deficit in micronutrients, 7

hypermetabolism and an excessive loss of nitrogen, are all factors known to predispose infection. 8

Furthermore, obesity has a strong link to respiratory diseases. It is widely known to be associated 9

with asthma, obstructive sleep apnoea, acute lung damage and ARDS 14 (acute respiratory distress 10 syndrome). Therefore, the association of severe pulmonary complications from COVID-19 and 11

obesity is now assessed, and obesity is a known risk factor for severe outcome also in other form of 12 pandemic influenza like H1N1. identify malnutrition as a possible risk factor for COVID-19, but, due to the lack of clinical trials 39 and the lack of homogenous large populations to be sampled, this association needs further 40 research 23,24 . 41

From an additional literature review, the MUST index was identified as a primary assessment tool 42

to evaluate the risk of malnutrition in patients that resulted positive for COVID-19 27 . This tool is 43 quick and easy to apply, with a sensibility of 79% and a specificity of 91% 28 . A systematic review 29 44 that evaluated the use of different assessment scales for malnutritional risk in COVID-19 positive 45

patients, came to the conclusion that the MUST index and Mini Nutritional Assessment have an 46

increased predictive validity in patients infected with SARS-CoV-2. 47

The MUST index analyses three criteria: BMI, weight changes in the past 3-6 month and 48 no nutritional intake or likelihood of no intake for more than 5 days associated with an acute 49

illness. 50 51 J o u r n a l P r e -p r o o f Statistical analysis 1 Data were described as number and percentage or mean and standard deviation or median and 2 interquartile range, as appropriated. Adherence to Gaussian distribution was verified with Shapiro-3

Wilk test. Differences among groups were explored with Kruskal Wallis test or ANOVA, as 4

appropriate. Due to the fact that MUST index was not calculated on obese patients, a subgroup 5 analysis was performed in obese and non-obese patients. 6

Association with mortality was explored with Cox regression. Independent variables with a p-value 7 under 0.2 were then submitted to a multivariable Cox regression. A p-value under 0.05 was 8 considered significant. All analyses were performed with Stata 15. 9

Demographic data and outcome measures were collected in an excel sheet in anonymous form and 10 collected by an investigator not involved in assistance, to promote independence in data collection. 11

The dataset was subdivided in four sections: admission data (gender, age, BMI, vital sign collected 12

in ER, fasting, enteral nutrition activation, weight variation, previous pathologies), MUST value 13 retrospectively calculated by the investigator, hospitalisation data (decubitus lesions, 14

superinfections, oxygen therapy, ICU admission), and discharge data (hospitalisation length, patient 15 status ad discharge) 16

As for superinfections patients diagnosed with positive blood cultures, pharyngeal swaps and 17

bronchial aspirate were taken into consideration. 18

The MUST index score was calculated based on the data given on the patient record 28 . Factors that 19

affect the patient for fasting such as: C-PAP, non-invasive ventilation, oxygen masks with an 20 oxygen flow over 10 L/min and Venturi mask with FiO2 over 50% were taken into consideration. p<0.001) and intubation at admission (respectively 11 (2.1%), vs 11 (11.5%), vs 4 (14.8%), 29

p<0.001).

The analysis was limited to 515 patients, from whom 353 (68.5%) males, with also discharge 31 complete information. Examining this cohort, we estimated the prevalence of malnutrition using the 32 MUST index, showing an average risk of malnutrition (MUST=1) in 13 (2.5%) patients and higher 33 risk (MUST≥2) in 80 (15.5%) patients, for a total of patients at risk of 18.1%. The data were 34

analysed dividing the cohort based on the outcome of the disease (table 1) . The multivariable 35

analysis shows that the association between the MUST index with mortality is maintained (HR 36

1.25, 95% CI 1.04-1.51, p=0.019) even after the corrections of age, treated hypertension, admission 37

to an intensive care unit and oxygen therapy. 38

Using the same cohort, we analysed the data for morbidity at discharge: from 515 patients with 39

clinical outcome data at discharge, 358 were discharged, 65 were transferred to other care facilities 40

due to clinical problems and 92 deceased ( for morbidity at discharge in this subgroup. These patients also showed a statistically significant 1 association of MUST index score and clinical outcome at discharge (data not showed).

In the subgroup of the 128 obese patients, from whom 83 (64.8%) male, the most relevant indicator 4

for outcome from a clinical point of view is the BMI, being directly proportional to mortality. 5

In patients with a BMI>30 transferred to other care facilities mortality was associated with age, 6 BMI, intubation, oxygen therapy, dysphagia, as well as an increase in the average length of 7 hospitalisation. 8

This study was carried out with the aim of investigating the association between the risk of 10 malnutrition recorded in the Emergency Department and patients hospitalised due to COVID-19, 11

the clinical outcomes of hospitalisation and the morbidity at discharge. 12

As for the evaluation of the nutritional risk, identified with the MUST index, the data show a close 13 association between the risk -score and the gravity of the disease. Therefore, the MUST index 14 could foretell the outcome of the hospitalisation, regardless of the factors named above. 15

The average score of the MUST index has shown to be higher in patients that were discharged with 16 clinical problems or that deceased, in line with findings in literature, but our sample has a mean age 17 of 65.1±14.3 years, unlike other studies previously published in the literature 1, 22, 29 which included 18 a sample with higher ages and lower sample numbers, also our sample presented a lower 19

malnutrition risk (an average value in all groups below 1) 20

Just as in previous studies 30 our study highlighted that arterial hypertension, suffering from a 21 neoplastic disease or hospitalisation in an intensive care unit are risk factors for severe clinical 22

outcomes. 23

The secondary analysis of obese patients showed an increase in mortality risk directly linked to an 24 increase in age and BMI, underlying diseases like arterial hypertension, diabetes or renal failure 25

were also taken into consideration. These outcomes are confirmed by various articles found in 26 literature that examined this association 25 . This demonstrates that obese patients are at higher risk of 27 a severe evolution of SARS-CoV2 infection and its associated mortality.

A limit of this study is the retrospective nature of the analysis. Another limitation to the study is the 29 fact that the analysis was only carried out on a specific subgroup not representative of the general 30 population, inasmuch the analysed groups patient data available differed. Therefore, the results can 31

only be generalised to a limited extent. 32

Further studies, possibly prospective researches, are therefore needed to obtain a better 33 comprehension of the impact of malnutrition on the outcome of hospitalised COVID-19 patients. 

Obesity and SARS-CoV-2: A population to safeguard

COVID-19 severity in obese patients: Potential mechanisms and 3 molecular targets for clinical intervention

ACE2/Ang 1-7 axis: a critical regulator of epicardial 6 adipose tissue inflammation and cardiac dysfunction in obesity

Malnutrition and nutritional therapy in patients with

SARS-CoV-2 disease

The Malnutritional Status of the Host as a 11 Virulence Factor for New Coronavirus SARS-CoV-2

Severe SARS-CoV-2 infections: practical 14 considerations and management strategy for intensivists

Prevalence of malnutrition and analysis of related factors 17 in elderly patients with COVID-19 in Wuhan, China

Nutritional status, diet and viral respiratory 20 infections: perspectives for severe acute respiratory syndrome coronavirus

Individuals with obesity and COVID-19: A global 25 perspective on the epidemiology and biological relationships

Higher body mass index is an important risk factor 28 in COVID-19 patients: a systematic review and meta-analysis. Environmental Science and 29 Pollution Research

Nutritional screening of adults: a multidisciplinary 34 responsibility

Nutritional Risk Screening Tools for Older Adults with COVID-19: 36 A Systematic Review

Prevalence of comorbidities and its effects in patients infected 38 with SARS-CoV-2: a systematic review and meta-analysis